Title:Relationship between COVID-19 and Neurological Disorder
Volume: 4
Issue: 4
Author(s): Shivendra Mani Tripathi, Pratik Kumar Vishwakarma, Smriti Ojha and Sudhanshu Mishra*
Affiliation:
- Department of Pharmaceutical Science & Technology, Madan Mohan Malaviya University of Technology, Gorakhpur,
Uttar Pradesh, India
Keywords:
COVID-19, dementia, SARS-CoV-2, haemorrhage, neuropsychiatric symptoms, alzheimer's.
Abstract: The COVID-19 pandemic has resulted in a socially isolating way of life, and dementia
patients are among those who are most affected. Lockdown procedures and the inability to monitor
illnesses have led to a rapid decline in cognitive function in these individuals, with neuropsychiatric
symptoms, such as agitation, delirium, and impaired motor performance being prevalent. However, the
use of antipsychotics in treating these symptoms can increase the risk of death during COVID-19. Effective
pain therapy can be used as an alternative to reduce or avoid the use of antipsychotics, given the
consistent relationship between agitation and pain in dementia patients. The importance of properly
assessing and managing pain in dementia patients is highlighted. Additionally, the article discusses
how COVID-19 can affect brain health through inflammation, blood clotting, and blood vessel damage,
leading to potential long-term effects on cognitive function. Healthcare professionals must be
aware of the increased risk of neuropsychiatric symptoms in dementia patients during the pandemic
and prioritize pain management as a viable alternative to antipsychotics. Proper care and attention are
necessary to prevent cognitive decline and potential long-term effects on brain health in these vulnerable
individuals.
